Bo Kruse

Director of Finance/CFO en Y-MABS THERAPEUTICS, INC. .

Fortuna: 3 M $ al 30/04/2024

52 años

43 relaciones

Health Technology

Consumer Services

Commercial Services

Relaciones activas

Nombre	Sexo	Edad	Empresas relacionadas	Colaboración
Thomas Gad	M	54	Y-MABS THERAPEUTICS, INC.	9 años
James Healy	M	58	Y-MABS THERAPEUTICS, INC.	7 años
Michael Rossi	M	53	Y-MABS THERAPEUTICS, INC.	1 años
David Gill	M	69	Y-MABS THERAPEUTICS, INC.	7 años
Johan Ernst Wedell-Wedellsborg	M	54	Y-MABS THERAPEUTICS, INC.	9 años
Ashutosh Tyagi	M	47	Y-MABS THERAPEUTICS, INC.	7 años
Gérard Ber	M	66	Y-MABS THERAPEUTICS, INC.	6 años
Anthony Pagano	M	46	GENMAB A/S	17 años
Martine van Vugt	M	71	GENMAB A/S	23 años
Joris Wilms	M	50	Y-MABS THERAPEUTICS, INC.	8 años
Laura Hamill	F	60	Y-MABS THERAPEUTICS, INC.	4 años
Anders Gersel Pedersen	M	73	GENMAB A/S	21 años
Torben Lund-Hansen	M	73	Y-MABS THERAPEUTICS, INC.	8 años
Birgitte Stephensen	F	63	GENMAB A/S	22 años
Vignesh Rajah	M	59	Y-MABS THERAPEUTICS, INC.	4 años
Sue Smith	F	54	Y-MABS THERAPEUTICS, INC.	2 años

Gráfico relacional

Relaciones con varias empresas

Antiguas relaciones

Nombre	Sexo	Edad	Empresas relacionadas	Colaboración
Claus Juan Møller-San Pedro	M	62	Y-MABS THERAPEUTICS, INC. Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	28 años
Michael Blair Widmer	M	76	GENMAB A/S	11 años
Michael Buschle	M	64	Y-MABS THERAPEUTICS, INC.	1 años
Christina Hahner	F	-	GENMAB A/S	-
Daniel John Bruno	M	45	GENMAB A/S	5 años
Michael K. Bauer	M	60	GENMAB A/S	14 años
Burt Malkiel	M	90	GENMAB A/S	11 años
Nedjad Losic	M	54	GENMAB A/S	-
Tom Vink	M	61	GENMAB A/S	-
Steen Lisby	M	60	Y-MABS THERAPEUTICS, INC. GENMAB A/S	16 años
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 años
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 años
Jorgen Petersen	M	-	GENMAB A/S	-
Rikke Glahn Ren	F	-	GENMAB A/S	-
Jens Munch-Hansen	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 años
Philip Herman	M	-	Y-MABS THERAPEUTICS, INC.	3 años
Patrick van Berkel	M	55	GENMAB A/S	9 años
Irwin Lerner	M	93	GENMAB A/S	-
Per Gullestrup	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 años
Hanne Damgaard Jensen	F	-	GENMAB A/S	8 años
Paul W. H. I. Parren	M	60	GENMAB A/S	16 años
Annarie Lyles	M	63	GENMAB A/S	-
David Andrew Eatwell	M	63	GENMAB A/S	12 años
Joseph Fred Yospe	M	66	GENMAB A/S	2 años
Michael Wolff Jensen	M	53	GENMAB A/S	3 años
Greg Raskin	M	51	Y-MABS THERAPEUTICS, INC.	5 años
Eva Ehrnrooth	M	57	GENMAB A/S	2 años

Estadísticas

País	Relaciones	% del total
Dinamarca	28	65.12%
Estados Unidos	17	39.53%

Antigüedad de la relación

Activas

Pasados

Hombre

Mujer

Administradores

Ejecutivos

Origen de las relaciones